Alexander Solms
8PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Sep 19, 2024
Population pharmacokinetic-pharmacodynamic model of elinzanetant based on integrated clinical phase I and II data.Stefan Willmann, Adam Lloyd, Rupert Austin
|Apr 02, 2024
Pharmacokinetics, pharmacodynamics, and safety of fesomersen, a novel antisense inhibitor of factor XI, in healthy Chinese, Japanese, and Caucasian volunteers.Tianxing Liu, Kensei Hashizume, Eva Krieg
|Sep 06, 2023
Assessing QTc Effects of Vericiguat Using Two Different Concentration-QTc Modeling Approaches.Hauke Ruehs, Alexander Solms, Matthias Frei
|Jul 09, 2023
Hepatotoxicity of AKR1C3 Inhibitor BAY1128688: Findings from an Early Terminated Phase IIa Trial for the Treatment of Endometriosis.Jan Hilpert, Esther Groettrup-Wolfers, Hristiyan Kosturski
|Feb 21, 2023
Opportunities and Challenges of Disease Progression Modeling in Drug Development - An IQ Perspective.Kosalaram Goteti, Nathan Hanan, Mindy Magee
|Sep 25, 2020
Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A.Alexander Solms, Anita Shah, Erik Berntorp
Pageof 2
Frequent Collaborators
2 joint publications
Anita Shah
2 joint publications
Stefan Willmann
1 joint publications
Alfonso Iorio
1 joint publications
Maurice J Ahsman
1 joint publications
Erik Berntorp
1 joint publications
Gili Kenet
1 joint publications
Kosalaram Goteti
1 joint publications
Sven Mensing
1 joint publications
Theodore Robert Rieger
1 joint publications
Jan Hilpert
